Levitsky Hyam has filed 3 insider transactions across 2 companies since March 2024.
Most recent transaction: a grant/award of 32000 shares of Replimune Group, Inc. ($REPL) on April 01, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2024 | Replimune Group, Inc. | $REPL | Levitsky Hyam | Director | A | Stock Option (right to buy) | 32000 | $0.00 | 32,000.0000 | 66,569,894 | 9999.99% | 0.05% |
| March 7, 2024 | Century Therapeutics, Inc. | $IPSC | Levitsky Hyam | President of R&D | A | Common Stock | 24000 | $0.00 | 560,544.0000 | 59,314,389 | 4.47% | 0.04% |
| March 7, 2024 | Century Therapeutics, Inc. | $IPSC | Levitsky Hyam | President of R&D | A | Stock Option (right to buy) | 146000 | $0.00 | 146,000.0000 | 59,314,389 | 9999.99% | 0.25% |